Perturbation of the lipid phase of a membrane is not involved in the modulation of MRP1 transport activity by flavonoids

[1] Hipfner, D.R., Deeley, R.G. and Cole, S.P. Structural, mechanistic and clinical aspects of MRP1. Biochim. Biophys. Acta 1461 (1999) 359–376. http://dx.doi.org/10.1016/S0005-2736(99)00168-610.1016/S0005-2736(99)00168-6Search in Google Scholar

[2] Keppler, D., Leier, I. and Jedlitschky, G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol. Chem. 378 (1997) 787–791. Search in Google Scholar

[3] Kamp, D. and Haest, C.W. Evidence for a role of the multidrug resistance protein (MRP) in the outward translocation of NBD-phospholipids in the erythrocyte membrane. Biochim. Biophys. Acta 1372 (1998) 91–101. http://dx.doi.org/10.1016/S0005-2736(98)00049-210.1016/S0005-2736(98)00049-2Search in Google Scholar

[4] Dekkers, D.W., Comfurius, P., van Gool, R.G., Bevers, E.M. and Zwaal, R.F. Multidrug resistance protein 1 regulates lipid asymmetry in erythrocyte membranes. Biochem. J. 350 (2000) 531–535. http://dx.doi.org/10.1042/0264-6021:350053110.1042/bj3500531Search in Google Scholar

[5] Raggers, R.J., van Helvoort, A., Evers, R. and van Meer, G.R.J. The human multidrug resistance protein MRP1 translocates sphingolipid analogs across the plasma membrane. J. Cell. Sci. 112 (1999) 415–422. Search in Google Scholar

[6] Harborne, J.B. and Williams, C.A. Advances in flavonoid research since 1992. Phytochemistry 55 (2000) 481–504. http://dx.doi.org/10.1016/S0031-9422(00)00235-110.1016/S0031-9422(00)00235-1Search in Google Scholar

[7] Dixon, R.A. and Ferreira, D. Genistein. Phytochemistry 60 (2000) 205–211. http://dx.doi.org/10.1016/S0031-9422(02)00116-410.1016/S0031-9422(02)00116-4Search in Google Scholar

[8] Heim, K.E., Tagliaferro, A.R. and Bobilya, D.J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 13 (2002) 572–584. http://dx.doi.org/10.1016/S0955-2863(02)00208-510.1016/S0955-2863(02)00208-5Search in Google Scholar

[9] Leslie, E.M., Mao, Q., Oleschuk, C.J., Deeley, R.G. and Cole, S.P. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol. Pharmacol. 59 (2001) 1171–1180. Search in Google Scholar

[10] Nguyen, H., Zhang, S. and Morris, M.E. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J. Pharm. Sci. 92 (2003) 250–257. http://dx.doi.org/10.1002/jps.1028310.1002/jps.10283Search in Google Scholar

[11] Bobrowska-Hagerstrand, M., Wrobel, A., Mrowczynska, L., Soderstrom, T., Shirataki, Y., Motohashi, N., Molnar, J., Michalak, K. and Hagerstrand, H. Flavonoids as inhibitors of MRP1-like efflux activity in human erythrocytes. A structure-activity relationship study. Oncol. Res. 13 (2003) 463–469. Search in Google Scholar

[12] Lania-Pietrzak, B., Michalak, K., Hendrich, A.B., Mosiadz, D., Grynkiewicz, G., Motohashi, N. and Shirataki, Y. Modulation of MRP1 protein transport by plant, and synthetically modified flavonoids. Life Sci. 77 (2005) 1879–1891. http://dx.doi.org/10.1016/j.lfs.2005.04.00510.1016/j.lfs.2005.04.005Search in Google Scholar

[13] Critchfield, J.W., Welsh, C.J., Phang, J.M. and Yeh, G.C. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem. Pharmacol. 48 (1994 1437–1445. http://dx.doi.org/10.1016/0006-2952(94)90568-110.1016/0006-2952(94)90568-1Search in Google Scholar

[14] Zhang, S. and Morris, M.E. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J. Pharmacol. Exp. Ther. 304 (2003) 1258–1267. http://dx.doi.org/10.1124/jpet.102.04441210.1124/jpet.102.044412Search in Google Scholar PubMed

[15] Imai, Y., Tsukahara, S., Asada, S. and Sugimoto, Y. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res. 64 (2004) 4346–4352. http://dx.doi.org/10.1158/0008-5472.CAN-04-007810.1158/0008-5472.CAN-04-0078Search in Google Scholar

[16] Ferte, J. Analysis of the tangled relationships between P-glycoprotein-mediated multidrug resistance and the lipid phase of the cell membrane. Eur. J. Biochem. 267 (2000) 277–294. http://dx.doi.org/10.1046/j.1432-1327.2000.01046.x10.1046/j.1432-1327.2000.01046.xSearch in Google Scholar

[17] Hendrich, A.B. and Michalak, K. Lipids as a target for drugs modulating multidrug resistance of cancer cells. Curr. Drug Targets 4 (2003) 23–30. http://dx.doi.org/10.2174/138945003334717210.2174/1389450033347172Search in Google Scholar

[18] Zordan-Nudo, T., Ling, V., Liu, Z. and Georges, E. Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance. Cancer Res. 53 (1993) 5994–6000. Search in Google Scholar

[19] Ford, J.M. and Hait, W.N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42 (1990) 155–199. Search in Google Scholar

[20] Wadkins, R.M. and Houghton, P.J. The role of drug-lipid interactions in the biological activity of modulators of multi-drug resistance. Biochim. Biophys. Acta 1153 (1993) 225–236. http://dx.doi.org/10.1016/0005-2736(93)90409-S10.1016/0005-2736(93)90409-SSearch in Google Scholar

[21] Drori, S., Eytan, G.D. and Assaraf, Y.G. Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur. J. Biochem. 228 (1995) 1020–1029. http://dx.doi.org/10.1111/j.1432-1033.1995.tb20352.x10.1111/j.1432-1033.1995.tb20352.xSearch in Google Scholar

[22] Pajeva, I.K., Wiese, M., Cordes, H.P. and Seydel, J.K. Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability. J. Cancer Res. Clin. Oncol. 122 (1996) 27–40. http://dx.doi.org/10.1007/BF0120307010.1007/BF01203070Search in Google Scholar

[23] Hendrich, A.B., Wesolowska, O., Motohashi, N., Molnar, J. and Michalak, K. New phenothiazine-type multidrug resistance modifiers: anti-MDR activity versus membrane perturbing potency. Biochem. Biophys. Res. Commun. 304 (2003) 260–265. http://dx.doi.org/10.1016/S0006-291X(03)00580-110.1016/S0006-291X(03)00580-1Search in Google Scholar

[24] Bobrowska-Hagerstrand, M., Wrobel, A., Mrowczynska, L., Soderstrom, T. and Hagerstrand, H. Modulation of MRP1-like efflux activity in human erythrocytes caused by membrane perturbing agents. Mol. Membr. Biol. 20 (2003) 255–259. http://dx.doi.org/10.1080/096876803100010632010.1080/0968768031000106320Search in Google Scholar

[25] Alqawi, O. and Georges, E. The multidrug resistance protein ABCC1 drug-binding domains show selective sensitivity to mild detergents. Biochem. Biophys. Res. Commun. 303 (2003) 1135–1141. http://dx.doi.org/10.1016/S0006-291X(03)00492-310.1016/S0006-291X(03)00492-3Search in Google Scholar

[26] Marbeuf-Gueye, C., Stierle, V., Sudwan, P., Salerno, M. and Garnier-Suillerot, A. Perturbation of membrane microdomains in GLC4 multidrug-resistant lung cancer cells-modification of ABCC1 (MRP1) localization and functionality. FEBS J. 274 (2007) 1470–1480. http://dx.doi.org/10.1111/j.1742-4658.2007.05688.x10.1111/j.1742-4658.2007.05688.xSearch in Google Scholar PubMed

[27] Klappe, K., Hinrichs, J.W., Kroesen, B.J., Sietsma, H. and Kok, J.W. MRP1 and glucosylceramide are coordinately over expressed and enriched in rafts during multidrug resistance acquisition in colon cancer cells. Int. J. Cancer 110 (2004) 511–522. http://dx.doi.org/10.1002/ijc.2014010.1002/ijc.20140Search in Google Scholar

[28] Hendrich, A.B. Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds. Acta Pharmacol. Sin. 27 (2006) 27–40. http://dx.doi.org/10.1111/j.1745-7254.2006.00238.x10.1111/j.1745-7254.2006.00238.xSearch in Google Scholar

[29] Trompier, D., Baubichon-Cortay, H., Chang, X.B., Maitrejean, M., Barron, D., Riordon, J.R. and Di Pietro, A. Multiple flavonoid-binding sites within multidrug resistance protein MRP1. Cell. Mol. Life Sci. 60 (2003) 1–14. http://dx.doi.org/10.1007/s00018030000010.1007/s000180300000Search in Google Scholar

[30] Wu, C.P., Calcagno, A.M., Hladky, S.B., Ambudkar, S.V. and Barrand, M.A. Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5). FEBS J. 272 (2005) 4725–4740. http://dx.doi.org/10.1111/j.1742-4658.2005.04888.x10.1111/j.1742-4658.2005.04888.xSearch in Google Scholar

[31] Steck, T.L. and Kant, J.A. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol. 31 (1973) 172–180. http://dx.doi.org/10.1016/0076-6879(74)31019-110.1016/0076-6879(74)31019-1Search in Google Scholar

[32] Lowry, O.H., Roserbrough, N.J., Farr, A.L. and Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265–275. Search in Google Scholar

[33] Rychlik, B., Balcerczyk, A., Klimczak, A. and Bartosz, G. The role of multidrug resistance protein 1 (MRP1) in transport of fluorescent anions across the human erythrocyte membrane. J. Membr. Biol. 193 (2003) 79–90. http://dx.doi.org/10.1007/s00232-002-2009-110.1007/s00232-002-2009-1Search in Google Scholar

[34] Van Veldhoven, P.P. and Mannaerts, G.P. Inorganic and organic phosphate measurements in the nanomolar range. Anal. Biochem. 161 (1987) 45–48. http://dx.doi.org/10.1016/0003-2697(87)90649-X10.1016/0003-2697(87)90649-XSearch in Google Scholar

[35] Ferreira, M.J., Gyemant, N., Madureira, A.M., Tanaka, M., Koos, K., Didziapetris, R. and Molnar, J. The effects of jatrophane derivatives on the reversion of MDR1-and MRP-mediated multidrug resistance in the MDAMB-231 (HTB-26) cell line. Anticancer Res. 25 (2005) 4173–4178. Search in Google Scholar

[36] Matsumoto, Y., Takano, H., Kunishio, K., Nagao, S. and Fojo, T. Expression of drug resistance genes in VP-16 and mAMSA-selected human carcinoma cells. Jpn. J. Cancer Res. 92 (2001) 778–784. Search in Google Scholar

[37] Pastan, I., Gottesman, M.M., Ueda, K., Lovelace, E., Rutherford, A.V. and Willingham, M.C. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl. Acad. Sci. USA 85 (1988) 4486–4490. http://dx.doi.org/10.1073/pnas.85.12.448610.1073/pnas.85.12.4486Search in Google Scholar PubMed PubMed Central

[38] Ghose, A.K., Pritchett, A. and Crippen, G.M. Atomic physicochemical parameters for three dimensional structure activity relationships III: modelling hydrophobic interactions. J. Comput. Chem. 9 (1988) 80–90. http://dx.doi.org/10.1002/jcc.54009011110.1002/jcc.540090111Search in Google Scholar

[39] Pulaski, L., Jedlitschky, G., Leier, I., Buchholz, U. and Keppler, D. Identification of the multidrug-resistance protein (MRP) as the glutathione-S-conjugate export pump of erythrocytes. Eur. J. Biochem. 241 (1996) 644–648. http://dx.doi.org/10.1111/j.1432-1033.1996.00644.x10.1111/j.1432-1033.1996.00644.xSearch in Google Scholar PubMed

[40] Klokouzas, A., Wu, C.P., van Veen, H.W., Barrand, M.A. and Hladky, S.B. cGMP and glutathione-conjugate transport in human erythrocytes. Eur. J. Biochem. 270 (2003) 3696–3708. http://dx.doi.org/10.1046/j.1432-1033.2003.03753.x10.1046/j.1432-1033.2003.03753.xSearch in Google Scholar

[41] Jedlitschky, G., Burchell, B. and Keppler, D. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J. Biol. Chem. 275 (2000) 30069–30074. http://dx.doi.org/10.1074/jbc.M00546320010.1074/jbc.M005463200Search in Google Scholar

[42] Wesolowska, O., Mosiadz, D., Motohashi, N., Kawase, M. and Michalak, K. Phenothiazine maleates stimulate MRP1 transport activity in human erythrocytes. Biochim. Biophys. Acta 1720 (2005) 52–58. http://dx.doi.org/10.1016/j.bbamem.2005.11.01110.1016/j.bbamem.2005.11.011Search in Google Scholar

[43] McAleer, M.A., Breen, M.A., White, N.L. and Matthews, N. pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when over-expressed in human embryonic kidney 293 cells. J. Biol. Chem. 274 (1999) 23541–23548. http://dx.doi.org/10.1074/jbc.274.33.2354110.1074/jbc.274.33.23541Search in Google Scholar

[44] Klokouzas, A., Barrand, M.A. and Hladky, S.B. Effects of clotrimazole on transport mediated by multidrug resistance associated protein 1 (MRP1) in human erythrocytes and tumour cells. FEBS Lett. 268 (2001) 6569–6577. Search in Google Scholar

[45] Rychlik, B., Pulaski, L., Sokal, A., Soszynski, M. and Bartosz, G. Transport of organic anions by multidrug resistance-associated protein in the erythrocyte. Acta Biochim. Pol. 47 (2000) 763–772. Search in Google Scholar

[46] Bobrowska-Hagerstrand, M., Wrobel, A., Rychlik, B., Bartosz, G., Soderstrom, T., Shirataki, Y., Motohashi, N., Molnar, J., Michalak, K. and Hagerstrand, H. Monitoring of MRP-like activity in human erythrocytes: inhibitory effect of isoflavones. Blood Cells Mol. Dis. 27 (2001) 894–900. http://dx.doi.org/10.1006/bcmd.2001.045910.1006/bcmd.2001.0459Search in Google Scholar

[47] van Zanden, J.J., Wortelboer, H.M., Bijlsma, S., Punt, A., Usta, M., Bladeren, P.J., Rietjens, I.M. and Cnubben, N.H. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. Biochem. Pharmacol. 69 (2005) 699–708. http://dx.doi.org/10.1016/j.bcp.2004.11.00210.1016/j.bcp.2004.11.002Search in Google Scholar

[48] van Zanden, J.J., de Mul, A., Wortelboer, H.M., Usta, M., van Bladeren, P.J., Rietjens, I.M. and Cnubben, N.H. Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin. Biochem. Pharmacol. 69 (2005) 1657–1665. http://dx.doi.org/10.1016/j.bcp.2005.03.00110.1016/j.bcp.2005.03.001Search in Google Scholar

[49] Phang, J.M., Poore, C.M., Lopaczynska, J. and Yeh, G.C. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res. 53 (1993) 5977–5981. Search in Google Scholar

[50] Castro, A.F. and Altenberg, G.A. Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein. Biochem. Pharmacol. 53 (1997) 89–93. http://dx.doi.org/10.1016/S0006-2952(96)00657-010.1016/S0006-2952(96)00657-0Search in Google Scholar

[51] Boumendjel, A., Di Pietro, A., Dumontet, C. and Barron, D. Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. Med. Res. Rev. 22 (2002) 512–529. http://dx.doi.org/10.1002/med.1001510.1002/med.10015Search in Google Scholar

[52] Ikegawa, T., Ohtani, H., Koyabu, N., Juichi, M., Iwase, Y., Ito, C., Furukawa, H., Naito, M., Tsuruo, T. and Sawada, Y. Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett. 177 (2002) 89–93. http://dx.doi.org/10.1016/S0304-3835(01)00761-310.1016/S0304-3835(01)00761-3Search in Google Scholar

[53] Conseil, G., Baubichon-Cortay, H., Dayan, G., Jault, J.M., Barron, D. and Di Pietro, A. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP-and steroid-binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci. USA 95 (1998) 9831–9836. http://dx.doi.org/10.1073/pnas.95.17.983110.1073/pnas.95.17.9831Search in Google Scholar

[54] Hooijberg, J.H., Pinedo, H.M., Vrasdonk, C., Priebe, W., Lankelma, J. and Broxterman, H.J. The effect of glutathione on the ATPase activity of MRP1 in its natural membranes. FEBS Lett. 469 (2000) 47–51. http://dx.doi.org/10.1016/S0014-5793(00)01238-210.1016/S0014-5793(00)01238-2Search in Google Scholar

[55] Di Pietro, A., Conseil, G., Perez-Victoria, J.M., Dayan, G., Baubichon-Cortay, H., Trompier, D., Steinfels, E., Jault, J.M., de Wet, H., Maitrejean, M., Comte, G., Boumendjel, A., Mariotte, A.M., Dumontet, C., McIntosh, D.B., Goffeau, A., Castanys, S., Gamarro, F. and Barron, D. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell. Mol. Life Sci. 59 (2002) 307–322. http://dx.doi.org/10.1007/s00018-002-8424-810.1007/s00018-002-8424-8Search in Google Scholar

[56] Mao, Q., Leslie, E.M., Deeley, R.G. and Cole, S.P. ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells. Biochim. Biophys. Acta 1461 (1999) 69–82. http://dx.doi.org/10.1016/S0005-2736(99)00150-910.1016/S0005-2736(99)00150-9Search in Google Scholar

[57] Chang, X.B., Hou, Y.X. and Riordan, J.R. ATPase activity of purified multidrug resistance-associated protein. J. Biol. Chem. 272 (1997) 30962–30968. http://dx.doi.org/10.1074/jbc.272.49.3096210.1074/jbc.272.49.30962Search in Google Scholar

[58] Hooijberg, J.H., Broxterman, H.J., Heijn, M., Fles, D.L., Lankelma, J. and Pinedo, H.M. Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein. FEBS Lett. 413 (1997) 344–348. http://dx.doi.org/10.1016/S0014-5793(97)00940-X10.1016/S0014-5793(97)00940-XSearch in Google Scholar

[59] Hooijberg, J.H., Broxterman, H.J., Scheffer, G.L., Vrasdonk, C., Heijn, M., de Jong, M.C., Scheper, R.J., Lankelma, J. and Pinedo, H.M. Potent interaction of flavopiridol with MRP1. Br. J. Cancer 81 (1999) 269–276. http://dx.doi.org/10.1038/sj.bjc.669068710.1038/sj.bjc.6690687Search in Google Scholar

[60] Jain, M.K. and Wu, N.M. Effect of small molecules on the dipalmitoyl lecithin liposomal bilayer: III. Phase transition in lipid bilayer. J. Membr. Biol. 34 (1977) 157–201. http://dx.doi.org/10.1007/BF0187029910.1007/BF01870299Search in Google Scholar

[61] Saija, A., Bonina, F., Trombetta, D., Tomaino, A., Montenegro, L., Smeriglio, P. and Castelli, F. Flavonoid-biomembrane interactions: A calorimetric study on dipalmitoylphosphatidylcholine vesicles. Int. J. Pharmaceutics 124 (1995) 1–8. http://dx.doi.org/10.1016/0378-5173(95)00051-J10.1016/0378-5173(95)00051-JSearch in Google Scholar

[62] Hendrich, A.B., Malon, R., Pola, A., Shirataki, Y., Motohashi, N. and Michalak, K. Differential interaction of Sophora isoflavonoids with lipid bilayers. Eur. J. Pharm. Sci. 16 (2002) 201–208. http://dx.doi.org/10.1016/S0928-0987(02)00106-910.1016/S0928-0987(02)00106-9Search in Google Scholar

[63] Ollila, F., Haing, K., Vuorela, P., Vuorela, H. and Slotte, J.P. Characterization of flavonoid-biomembrane interactions. Arch. Biochem. Biophys. 399 (2002) 103–108. http://dx.doi.org/10.1006/abbi.2001.275910.1006/abbi.2001.2759Search in Google Scholar

[64] Bhowmik, B.B., Basu, S. and Ray, D. Photophysical studies of 3,3′ dioctadecyloxacarbocyanine dye in model biological membranes and different solvents. Chem. Phys. Lipids 109 (2001) 175–183. http://dx.doi.org/10.1016/S0009-3084(00)00218-810.1016/S0009-3084(00)00218-8Search in Google Scholar

[65] Sidorowicz, A., Pola, A. and Dobryszycki, P. Spectral properties of 3,3′-diethyloxadicarbocyanine included in phospholipid liposomes. J. Photochem. Photobiol. B 38 (1997) 94–97. http://dx.doi.org/10.1016/S1011-1344(96)07431-310.1016/S1011-1344(96)07431-3Search in Google Scholar

[66] Sidorowicz, A., Mora, C., Jablonka, S., Pola, A., Modrzycka, T., Mosiadz, D. and Michalak, K. Spectral properties of two betaine-type cyanine dyes in surfactant micelles and in the presence of phospholipids. J. Mol. Struct. 744–747 (2005) 711–716. http://dx.doi.org/10.1016/j.molstruc.2004.12.05310.1016/j.molstruc.2004.12.053Search in Google Scholar

[67] Krishna, M.M. and Periasamy, N. Location and orientation of DODCI in lipid bilayer membranes: effects of lipid chain length and unsaturation. Biochim. Biophys. Acta 1461 (1999) 58–68. http://dx.doi.org/10.1016/S0005-2736(99)00149-210.1016/S0005-2736(99)00149-2Search in Google Scholar

[68] Lopes, S. and Castanho, M.A. Does aliphatic chain length influence carbocyanines’ orientation in supported lipid multilayers? J. Fluorescence 14 (2004) 281–287. http://dx.doi.org/10.1023/B:JOFL.0000024560.17546.9710.1023/B:JOFL.0000024560.17546.97Search in Google Scholar

[69] Scheidt, H.A., Pampel, A., Nissler, L., Gebhardt, R. and Huster, D. Investigation of the membrane localization and distribution of flavonoids by high-resolution magic angle spinning NMR spectroscopy. Biochim. Biophys. Acta 1663 (2004) 97–107. http://dx.doi.org/10.1016/j.bbamem.2004.02.00410.1016/j.bbamem.2004.02.004Search in Google Scholar PubMed

[70] Siarheyeva, A., Lopez, J.J. and Glaubitz, C. Localization of multidrug transporter substrates within model membranes. Biochemistry 45 (2006) 6203–6211. http://dx.doi.org/10.1021/bi052487010.1021/bi0524870Search in Google Scholar PubMed

[71] Yu, J., Cheng, Y., Xie, L. and Zhang, R. Effects of genistein and daidzein on membrane characteristics of HCT cells. Nutr. Cancer 33 (1999) 100–104. http://dx.doi.org/10.1080/0163558990951475510.1080/01635589909514755Search in Google Scholar PubMed

[72] Oteiza, P.I., Erlejman, A.G., Verstraeten, S.V., Keen, C.L. and Fraga, C.G. Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface? Clin. Develop. Immunol. 12 (2005) 19–25. http://dx.doi.org/10.1080/1044667041000172216810.1080/10446670410001722168Search in Google Scholar PubMed PubMed Central